#Cholesterol Cut

Pelacarsen Heart Drug Fails Despite 78% Cholesterol Cut

A landmark trial has delivered a sobering result for heart medicine: a drug that cut a risky cholesterol marker by 78% did not prevent a single extra heart attack or stroke.